author-photo

Andrea Seidel-Glaetzer

Heidelberg University

2

Papers

28

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Safety and Preliminary Efficacy Results from a Phase II Study Evaluating Combined BRAF and MEK Inhibition in Relapsed/Refractory Multiple Myeloma (rrMM) Patients with Activating BRAF V600E Mutations: The GMMG-Birma Trial

2020 Blood
Show All
- Source
- Cite
- Save
Citations (8)
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

2019 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (20)